Thermo Fisher Scientific recently received U.S. 510(k) clearance for its EXENT System, an automated analyser aimed at ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced 510(k) clearance of the EXENT® Analyser and Immunoglobulin Isotypes (GAM) Assay**, a first-of-its-kind ...

Today's "Final Trades" segment focused on UnitedHealth, Thermo Fisher Scientific, iShares U.S. Healthcare ETF and Monster Beverage.

The FDA approved Johnson & Johnson ’s Darzalex for smoldering multiple myeloma. Thermo Fisher Scientific received 510 (k) clearance in the U.S. for its Exent System to aid in the diagnosis of multiple ...

Thermo Fisher Scientific received 510 (k) clearance from the Food and Drug Administration to market its EXENT system to aid in the diagnosis of multiple myeloma. The company's EXENT system detects and ...

Thermo Fisher Scientific has cleared a major regulatory hurdle in getting a new diagnostic tool for a type of blood cancer in ...

The FDA has granted 501 (k) clearance to the EXENT® System, a fully automated device for assessing monoclonal gammopathies, ...

Donaldson Company, Inc. (NYSE: DCI) held its annual meeting of stockholders today. Preliminary voting results indicate stockholders owning a majority of shares supported: ...

HOLX gains expanded CE marking for its Genius Digital Diagnostics System, enabling imaging of both cell and tissue specimens on one platform.

Johnson & Johnson entered into a definitive agreement to acquire Halda Therapeutics OpCo for $3.05 billion in cash. Eli Lilly announced it will pay $40 million upfront and up to $2.56 billion in a ...

Adds AI Agent for Building and Hosting Websites and Landing Pages to Banzai’s Growing Product SuiteSEATTLE, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ...

Designed for routine clinical use, the system can identify M-proteins based on their molecular weight to help diagnose multiple myeloma and related disorders.